Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9783539
SERIAL NO

15121847

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are certain indoloquinolone compounds, methods of preparation thereof, pharmaceutical compositions thereof, and uses thereof, such as their uses as ALK inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASCENTAGE PHARMA (SUZHOU) CO LTDSUZHOU JIANGSU 215000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bai, Longchuan Ann Arbor, US 23 177
Chen, Jianyong Ann Arbor, US 37 143
Guo, Ming Jiangsu, CN 25 124
Jiao, Lingling Jiangsu, CN 8 6
Jing, Yu Jiangsu, CN 18 25
Liu, Liu Ann Arbor, US 394 2825
McEachern, Donna Ann Arbor, US 21 152
Qian, Xu Jiangsu, CN 14 39
Wang, Shaomeng Superior Township, US 129 1098
Yang, Chao-Yie Ann Arbor, US 24 230
Yang, Dajun Jiangsu, CN 63 247
Zhou, Yunlong Jiangsu, CN 13 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 10, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 10, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00